Navigation Links
BioAstrum Announces New Transfection Tools Market Report
Date:7/31/2013

GERMANTOWN, Md., July 31, 2013 /PRNewswire-iReach/ -- BioAstrum Corp. announces the release of research report of 2013 commercial landscape in transfection tools market.  This report is a timely review of current companies and products in the market of transfection tools. Transfection is an essential method that is widely used in both biomedical research and pharmaceutical development.  The market for transfection tools is a well-serviced market space with many vendors providing hundreds of brand solutions of instrument, accessories and reagent that claim to bring better results at lower cost.   According to a number of published reports, the current global transfection market ranges from $260 - 385 million, with projected annual growth rates of 8-9% through 2015.   In this report, over 100 product brands from 20 different companies in the transfection market are examined. Top performing companies and product brands are reviewed and ranked.  Historical performance of product brands and companies are reviewed, and emerging trends in technology / up-and-coming product brands are identified. This report provides a snap shot of the current transfection tools market place that can be used for competitive analysis, product development, and other business purposes.

For a review of report content, visit the following web page:

http://bioastrum.com/home/content/transfection-market-landscape-2013

 

About BioAstrum:

BioAstrum is a consulting service company for the life science tools companies.  We are the leading advisor in Internet based marketing for biotech products. We provide the latest market intelligence data on biomedical research tools markets.  For more details about our service please visit our website at www.bioastrum.com.  Or contact Sean X. Yu at

Email: info@BioAstrum.com

Tel: 301-539-9888

Fax: 301-769-6301

 

Key topics covered

1     Market Research Methodology: Research Publication Citation Analysis. 

2     Current Transfection market space. 

3     Most valuable brands in transfection market 2013. 

4     2013 transfection market leaders: company ranking. 

5     Dynamics in Transfection Market 

6     Trend in transfection markets. 

7     Discussion and conclusive remarks.

Table 1. Transfection tools segments. 

Table 2. Companies and brands in transfection market space. 

Table 3. Most valuable brands in transfection market 2013. 

Table 4. Transfection market share by company 2013. 

Table 5. Life Technologies transfection product line up. 

Figure 1.  Lipofectamine trend. 

Figure 2. Key brand performance since 2000. 

Figure 3. Transfection segments.

Figure 4. Segment trend in transfection market 

Key Companies and products covered

Companies

Life Technologies

Roche/Promega

Lonza

Qiagen

ThermoFisher

Mirus

Polyplus-Transfection (VWR)

BioRad

Origene

EMD Millipore

BTX

Signagen

 

Brands

Lipofectamine

FuGENE 6 and FUGENE HD

Nucleofector

DharmaFECT

Oligofectamine

Effectene

HiPerfect

Ingenio

TransIT-XXX

JetPEI

Calcium Phosphate transfection 2

SuperFect

X-tremeGENE

Turbofect

GeneJuice

PolyFect

INTERFERin

Gene Pulser Xcell

DOTAP 2

siPORT NeoFX

Lullaby

ECM 830

Lipofectin

Media Contact: Sean Yu, BioAstrum Corp, 3015399888, sean.yu@bioastrum.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE BioAstrum Corp
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. MiMedx Announces Record Second Quarter Results
2. SoundConnect Announces Expansion into New York City and Washington D.C.
3. DryLet Technologies Announces the Rebranding and Launch of Patented ManureMagic™
4. Pittcon 2014 Announces Call for Topics for Conferee Networking Sessions
5. Celladon Corporation Announces Pre-clinical Study Demonstrating Inhalable MYDICAR Reverses Pulmonary Arterial Hypertension (PAH)
6. Amgen Announces 2013 Third Quarter Dividend
7. Hie Electronics Announces the Launch of Its TeraNimbus Cloud Archive and Backup and TeraNimbus Software
8. Boston Scientific Announces Results For Second Quarter Ended June 30, 2013
9. Sarcoma Alliance Announces Tissue Bank to Help Researchers
10. NYCEDC Announces Winners of Innovate Health Tech, Highlighting Innovation in NYCs Healthcare Sector
11. Signal Genetics Announces Publication of BreastPRS™ Validation Study with Weill Cornell Medical College, New York
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/31/2016)... ... ... Adimarket, a subsidiary of Global Stem Cells Group, Inc. is ... technology, and is expected to be available to physicians in July, 2016. The Progenikine ... fraction (SVF) in a closed environment. , Adipose derived stem cells (ASCs) are used ...
(Date:5/31/2016)... , ... May 30, 2016 , ... Doctors in Italy ... may live longer than patients with lower levels. Surviving Mesothelioma has just posted an ... Researchers at cancer centers in Genoa and La Spezia, Italy tested the blood serum, ...
(Date:5/27/2016)... , ... May 27, 2016 , ... PBI-Gordon Corporation is ... and Ornamental Products. , In his 15-year career with PBI-Gordon, Dave has served in ... where he was integral in the development and launch of many of PBI-Gordon’s most ...
(Date:5/26/2016)... ISELIN, New Jersey and ... -- Indegene ( http://www.indegene.com ), a ... solutions to life science, pharmaceutical and healthcare organisations ... provider of innovative scientific support throughout the product ... alliance with the launch of IntraScience. ...
Breaking Biology Technology:
(Date:4/26/2016)... and LONDON , April ... part of EdgeVerve Systems, a product subsidiary of ... today announced a partnership to integrate the Onegini ...      (Logo: http://photos.prnewswire.com/prnh/20151104/283829LOGO ) ... their customers enhanced security to access and transact ...
(Date:4/15/2016)... 2016 Research and Markets has ... Market 2016-2020,"  report to their offering.  , ... ,The global gait biometrics market is expected to ... period 2016-2020. Gait analysis generates multiple ... used to compute factors that are not or ...
(Date:3/31/2016)... -- Genomics firm Nabsys has completed a financial  restructuring under ... M.D., who returned to the company in October 2015. ... including Chief Technology Officer, John Oliver , Ph.D., ... Vice President of Software and Informatics, Michael Kaiser ... Bready served as CEO of Nabsys from 2005-2014 and ...
Breaking Biology News(10 mins):